New Delhi: In a landmark global achievement, India has overtaken the USA and become the top country in terms of global COVID-19 recoveries. India has reported the highest number of total recoveries with more than 42 lakh\u00a0(42,08,431) COVID patients recovered and discharged. India now accounts for close to\u00a019%\u00a0of the total global recoveries. This has strongly pushed the national Recovery Rate to nearly\u00a080%\u00a0(79.28%). Centre-led focussed, calibrated, responsive & effective measures of early identification through high & aggressive testing, prompt surveillance & tracking coupled with standardized high-quality clinical care have together resulted in this global achievement. In its determined and resolute fight against COVID-19, India has scaled another peak of registering the highest-ever single day recoveries in the last 24 hours. A total of 95,880 recoveries\u00a0have been recorded. 90% of the new recovered\u00a0cases are being reported from\u00a016 States\/UTs. Of the new recovered cases, about\u00a060% are being reported from five States, viz. Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka and Uttar Pradesh. Maharashtra has alone contributed more than 22,000 (23%) and Andhra Pradesh has contributed more than 11,000 (12.3%) to the single day recoveries. 90% of the Total Recovered\u00a0cases are being reported from\u00a015 States\/UTs. The top five States with the maximum caseload viz Maharashtra, Tamil Nadu, Andhra Pradesh, Karnataka and Uttar Pradesh are also nodal for highest number of Total Recoveries. India has maintained a sustained path of reporting very high number of recoveries. These are the result of focussed strategies leading to coordinated effective actions in the States\/UTs. The Ministry of Health & Family Welfare has issued a comprehensive Standard of Care clinical management and treatment protocols.\u00a0 Drawing from global emerging evidence, these have been regularly revised and strengthened. India has allowed for rational use of \u2018Investigational Therapies\u2019 like Remdesevir, convalescent plasma, and Tocilizumab and adopted measures such pruning, use of high flow oxygen, non-invasive ventilation, use of steroids and anti-coagulants to aid recovery in COVID patients. Supervised home\/facility isolation for mild and moderate cases, improved services of the ambulances for ferrying patients for prompt and timely treatment have enabled seamless and efficient patient management. AIIMS, New Delhi has handheld the States\/UTs for enhancing the clinical management skills of doctors in the ICUs, through the 'National e-ICU on COVID-19 Management' and Centers of Excellence. Held twice a week, on Tuesday and Friday, the sessions have aided in substantial increase of the total nationwide recovered cases and maintaining a low and steadily declining mortality rate.\u00a0 19 such National e-ICUs have been held covering 249 hospitals of 28 States\/UTs across the country, to date. The Centre has been regularly reviewing the assistance provided to the State\/UT governments. Several high level multi-specialist Central teams have been deployed in States\/UTs. These support them for strengthening Containment, Surveillance, Testing, and efficient Clinical Management. The Centre has also been regularly reviewing the availability of medical oxygen in hospitals\/health facilities. These have played a critical intervention role in India\u2019s high recoveries and maintained a low Case Fatality Rate (CFR), which currently stands at 1.61%.